当前位置：首页 > 文献互助 > 互助详情

期刊论文Combination ATR and PARP Inhibitor (CAPRI): a phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-sensitive epithelial ovarian cancer (cohort A)复制

用户1S1jGNoN7Zjg 2小时前 14 待确认帖子自动结束时间: 2025-08-20 17:36:42

1. 请及时下载文件确认是否正确, 系统将在 2025-08-22 17:50:13 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

互助时间线

jodie0105上传了文件(pdf 411.33 KB), 求助状态变成待确认

Preclinical evaluation of SC0245, a small molecule inhibitor of ATR kinase 1小时前

Unsupervised Spectral Demosaicing With Lightweight Spectral Attention Networks 1小时前

Few-Shot Learning Based on Embedded Self-Distillation and Adaptive Wasserstein Distance for Hyperspectral Image Classification 2小时前

A dual encoder crack segmentation network with Haar wavelet-based high–low frequency attention 3小时前

The topological properties of the protein universe 3小时前

Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson’s disease 3小时前

Sequence-Only Prediction of Binding Affinity Changes: A Robust and Interpretable Model for Antibody Engineering 3小时前

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer inhead and neck squamous cell carcinoma cell lines 3小时前